Kaival Brands Innovations Group
0.5719-0.01 (-1.77%)
Oct 29, 4:00:02 PM EDT · NasdaqCM · KAVL · USD
Key Stats
Market Cap
6.63MP/E (TTM)
-Basic EPS (TTM)
-0.61Dividend Yield
0%Recent Filings
8-K
Nasdaq grants compliance extension
Kaival Brands Innovations Group snagged a 180-day Nasdaq extension on October 2, 2025, pushing its bid price compliance deadline to March 30, 2026, after failing the $1 minimum rule flagged in April. The company plans a reverse stock split if needed to lift its stock above $1 for 10 straight business days. Trading under KAVL persists uninterrupted. Delisting looms without success.
8-K
Merger with Delta terminated
Kaival Brands Innovations Group terminated its merger agreement with Delta Corp Holdings Limited on September 11, 2025, scrapping the business combination announced last year. The mutual deal includes full releases from all claims, fees, and liabilities tied to the merger, plus a six-month ban on Delta trading KAVL stock or contacting key stakeholders. Deal's dead. This clears the deck but leaves Kaival to navigate growth solo amid regulatory hurdles in vaping.
10-Q
Q3 FY2025 results
Kaival Brands Innovations Group posted Q3 FY2025 revenue of $142K, down sharply from $714K a year ago, as product sales halted amid ITC patent claims and FDA hurdles on Bidi Stick imports. Royalty income from the PMI international license fell to $142K from $441K, yet gross margins hit 100% with zero cost of revenue. Operating expenses dropped to $701K from $1.8M, mainly from lower professional fees, but a $708K ROU asset loss and $2.9M YTD stock-based comp pushed net loss to $559K, or $0.05 per share on 11.5M diluted shares—wider than last year's $1.6M loss yet milder per share thanks to more shares. Cash dwindled to $1.3M after $2.0M operating outflow, with no debt but $767K lease liability under negotiation; the terminated Delta merger leaves focus on GoFire IP monetization. Regulatory scrutiny on ENDS products lingers as a key risk.
8-K
ATM equity offering launched
Kaival Brands Innovations Group entered an Equity Distribution Agreement with Maxim Group on August 15, 2025, enabling at-the-market sales of common stock up to $1.6 million in aggregate value. Shares will be sold through Nasdaq or other markets at prevailing prices, with Maxim earning 3.5% commission on gross proceeds. The deal terminates August 15, 2026, or earlier by mutual notice. This flexible capital raise bolsters liquidity without immediate dilution.
10-Q
Q2 FY2025 results
Kaival Brands Innovations Group posted Q2 FY2025 revenue of $47K, down sharply from $2.2M a year earlier, as product sales evaporated amid the ITC patent dispute halting Bidi Stick imports. Royalty income from the PMI license held steady at $43K, but gross margins soared to 100% with zero costs, while operating expenses climbed to $2.1M on a $708K right-of-use asset loss from lease termination, driving a $2.0M net loss versus $1.5M last year. YTD through April 30, 2025, revenue fell to $250K from $5.4M, with net loss widening to $6.1M or $0.58 per share on 10.5M diluted shares, reconciled without anti-dilution. Cash drained to $1.8M after $1.5M operating outflow, with no debt but ongoing merger talks with Delta. Regulatory hurdles persist from FDA denial orders.
BTI
British American Tobacco Indus
51.72-0.74
CHUC
Charlie's Holdings, Inc.
0.27-0.01
KGKG
KONA GOLD BEVERAGE INC.
0.00+0.00
MO
Altria Group, Inc.
61.97-1.31
PM
Philip Morris International Inc
146.77-3.04
RLX
RLX Technology Inc.
2.39-0.03
SBEV
Splash Beverage Group, Inc. (NV
1.87-0.20
TOBAF
TAAT Global Alternatives Inc.
0.09+0.02
TPB
Turning Point Brands, Inc.
88.16-0.69
VPRB
VPR Brands, LP
0.05+0.00